Moreover, a clinical study demonstrated that injections of 99mTc-labelled ADAPT6 were safe, and that ADAPT6 accumulated in HER2-expressing breast cancer with high specificity [14]. This evidence concerns the gene ERBB2 and breast carcinoma.